Effects of hyperglycemia on oxidative stress and antioxidant potential in patients with type 2 diabetes

Diabetology International

Volumn 1, Issue 2, 2010, Pages 72-77

  Ikebuchi, Motoyoshi ^a   Nishio, Yoshihiko ^b   Maegawa, Hiroshi ^b   Kashiwagi, Atsunori ^b  

^a Ikebuchi Clinic   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Antioxidant potential; Diabetes mellitus; Hyperglycemia; Metabolic syndrome; Oxidative stress

Indexed keywords

GLIMEPIRIDE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MIGLITOL; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84862867191     PISSN: 21901678     EISSN: 21901686     Source Type: Journal    
DOI: 10.1007/s13340-010-0008-5     Document Type: Article

References (21)

1. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care. 1996; 19: 257-67.
2. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis. JAMA. 2002; 287: 2570-81.
3. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001; 414: 813-20.
4. CerielloA Piconi L, Quagliaro L, Wang Y, Schnabel CA, Ruggles JA, Gloster MA, Maggs DG, Weyer C. Effects of pramlintide on postprandial glucose excursions and measures of oxidative stress in patients with type 1 diabetes. Diabetes Care. 2005; 28: 632-7.
5. Sakane N, Fujiwara S, Sano Y, Domichi M, Tsuzaki K, Matsuoka Y, Hamada T, Shiaga K, Kotani K. Oxidative stress, inflammation, and atherosclerotic changes in retinal arteries in the Japanese population; result from the Mima study. Endocr J. 2008; 55: 485-8.
6. Vassalle C, Pratali L, Boni C, Mercuri A, Ndreu R. An oxidative stress score as a combined measure of the pro-oxidant and anti-oxidant counterparts in patients with coronary artery disease. Clin Biochem. 2008; 41: 1162-7.
7. Nakayama K, Terawaki H, Nakayama M, Iwabuchi M, Sato T, Ito S. Reduction of serum antioxidative capacity during hemodialysis. Clin Exp Nephrol. 2007; 11: 218-24.
8. Nagata K, Hasegawa T, Hirokado Y, Kiyama K, Otsuki C. Lifestyle-related diseases and the oxidative stress regulation system. Jpn J Psychosom Med. 2008; 48: 177-83.
9. The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc. 2010; 53(6): 450-67.
10. Cornelli U, Terranova R, Luca S, Cornelli M, Alberti A. Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress. J Nutr. 2001; 131(12): 3208-11.
11. Cesarone MR, Belcaro G, Carratelli M, Cornelli U, De Sanctis MT, Incandela L, Barsotti A, Terranova R, Nicolaides A. A sipmple test to monitor oxidative stress. Int Angiol. 1999; 18: 127-30.
12. Iamele L, Fiocchi R, Vernocchi A. Evaluation of an automated spectrophotometric assay for reactive oxygen metabolites in serum. Clin Chem Lab Med. 2002; 40: 673-6.
13. Nishikawa T, Sasahara T, Kiritoshi S, Sonoda K, Senokuchi T, Matsuo T, Kukidome D, Wake N, Matsumura T, Miyamura N, Sakakida M, Kishikawa H, Araki E. Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes. Diabetes Care. 2003; 26: 1507-12.
14. Kashiwagi A, Asahina T, Nishio Y, Ikebuchi M, Tanaka Y, Kikkawa R, Shigeta Y. Glycation, oxidative stress, and scavenger activity: glucose metabolism and radical scavenger dysfunction in endothelial cells. Diabetes. 1996; 45(Suppl 3): S84-6.
15. Tsunekawa T, Hayashi T, Suzuki Y, Matsui-Hirai H, Kano H, Fukatsu A, Nomura N, Miyazaki A, Iguchi A. Plasma adiponectin plays an important role in improving insulin resistance with glimepiride in elderly type 2 diabetic subjects. Diabetes Care. 2003; 26: 285-9.
16. Kotani K, Sakane N, Tsuzaki K, Matsuoka Y, Sano Y, Hamada T, Yamada K. Lifestyles and oxidative stress in type 2 diabetic patients. Scand J Clin Lab Invest. 2008; 8: 1-3.
17. Meigs JB, Larson MG, Fox CS, Keaney JF Jr, Vasan RS, Benjamin EJ. Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study. Diabetes Care. 2007; 30: 2529-35.
18. Kaneto H, Nakatani Y, Kawamori D, Miyatsuka T, Matsuoka TA. Involvement of oxidative stress and the JNK pathway in glucose toxicity. Rev Diabet Stud. 2004; 1(4): 165-74.
19. Matés JM, Pérez-Gómez C, Núñez de Castro I. Antioxidant enzymes and human diseases. Clin Biochem. 1999; 32(8): 595-603.
20. Ceriello A, Morocutti A, Mercuri F, Quagliaro L, Moro M, Damante G, Viberti GC. Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes. 2000; 49: 2170-7.
21. 2 in high-glucose medium. Diabetes. 1995; 44: 520-6.